Category Archives: Lipitor Diabetes
History of Lipitor
Lipitor is a cholesterol lowering medication, belonging to a class of drugs known as statins. Statins have been used since the 1980’s to lower cholesterol.
Statins work by blocking a specific enzyme in the liver, which stops the body from producing more cholesterol. Statins usually will lower cholesterol levels after a two week course of medication, but are typically taken for longer periods of time, even years.
Lipitor is also called atorvastatin, which is the generic name of the drug. Lipitor was originally developed Warner-Lambert, a pharmaceutical company.
Warner-Lambert entered into a selling agreement with Pfizer, Inc., who would market and sell the drug. Pfizer later acquired Warner-Lambert in 2000.
Lipitor was given FDA approval for public use in late 1996, and first sold in 1997. It quickly became the most popular drug of all time, outselling all other pharmaceutical medicines of any kind. In the first 14.5 years after it’s release, Lipitor grossed over $125 billion in sales.
Lipitor raked in 20 to 25% of Pfizer’s overall sales for years.
Part of the success of Lipitor was because it is a particularly potent statin, and is very efficient in lowering LDL cholesterol levels. It is sometimes nicknamed the “turbostatin.”
In addition, there are claims that Lipitor was aggressively marketed, downplaying the risks and dangerous Lipitor side effects, which may account for some of its success as well. For more on the Lipitor side effects, click here.
Problems are seen with Lipitor Side Effects
There have been many prior studies on statin use and the risk of type II diabetes, but it was until 2004 that a study specifically examining Lipitor and type II diabetes was published.
This study was published in Circulation, and it examined the relationship between Lipitor and blood sugar. It found that people who take long term courses of Lipitor can have worsened ability to control blood sugar levels. The authors of this study stated that Lipitor decreased “glycemic control.”
With uncontrolled blood sugar levels, people taking Lipitor can eventually develop type II diabetes.
Another study published by the Lancet in 2010 confirmed the association between Lipitor and other statins with type II diabetes. These researchers found that taking Lipitor leads to a significantly increased the users chances of developing type II diabetes.
Another study published by the Journal of the American College of Cardiology published in 2011 confirmed: Lipitor increases the users’ risk of contracting type II diabetes significantly.
These and other medical studies caught the attention of the U.S. Food and Drug Administration (FDA).
FDA makes Changes in Lipitor Safety Labels
Lipitor was approved for sale in 1996, but it wasn’t until 2012 when the FDA ordered changes to be made to the safety label of Lipitor regarding the Lipitor diabetes risk.
On February 28th, 2012 the FDA issued a mandate that the drug companies must add another safety label to Lipitor and atorvastatin, warning that this medicine may significantly increase one’s likelihood of developing type II diabetes.
Unlike in other countries, Pfizer chose not to disclose the diabetes risk on the Lipitor bottles directly. Instead Pfizer placed a warning that the drug can potentially cause increased blood sugar levels.
However, claimants in the Lipitor lawsuit argue that this warning was not strong enough, and unclear. The Lipitor type II diabetes warning Pfizer added in response to the FDA mandate was worded as follows:
“Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor.”
The Lipitor Lawsuit
As Lipitor users across the U.S. began to develop type II diabetes from taking Lipitor, a public outcry began. Lipitor was released 16 years before Pfizer began to warn about Lipitor type II diabetes, a warning that came all too late for thousands of Americans.
If Pfizer had been more forthcoming about the risks of type II diabetes to both patients and the healthcare providers prescribing this medication, preventative action could have been taken.
For example, healthcare providers could have started monitoring their patient’s blood glucose level to see if a problem was developing. Lipitor users themselves could have made life style changes had they known of their increased risk of contracting diabetes.
The first Lipitor lawsuit was filed in the District of South Carolina by Evalina Smalls. Evaline began taking Lipitor in 1999 to prevent heart disease.
Despite her healthy lifestyle and otherwise low risk for diabetes, Evalina developed type II diabetes as a result of taking Lipitor. She alleges that she is now at risk of the complications associated with type II diabetes, including blindness, kidney disease, nerve damage, and yes, heart disease.
Evaline Smalls was not the only one affected, and the Lipitor lawsuits slowly started to increase. The Lipitor MDL , or Lipitor multidistrict litigation was created this year, as the number climbed from just a few Lipitor type II diabetes claims, to over 700. The Lipitor MDL will effectively organize the smiliar Lipitor type II diabetes claims and expedite pretrial procedures, including early settlements.
The Lipitor lawsuit is expected to go to trial in July of 2015.
We also assist people with a Risperdal Lawsuit if they suffer from gynoclamastia.
Hurt by Lipitor?
If you have been affected by Lipitor type II diabetes, you may be eligible for compensation with a Lipitor lawsuit. The medical bills, risks, and pain and suffering associated with Lipitor type II diabetes are not to be underestimated.
If you have been hurt by Lipitor, it is vital that you contact our team for legal representation. Our Lipitor lawyers are experienced, caring, and well-qualified to handle your case.
Call today for a free case evaluation to see if you may have a viable claim for a Lipitor lawsuit.
The art of Implementation is responsible for these pages
Developments in the Case Against Lipitor
The Lipitor settlement is ongoing for those women affected by the drug. Since the discovery that the drug can cause the user to develop type II diabetes, several women have filed lawsuits against the drug manufacturer.
Although the current litigation primarily focuses on post-menopausal women, all of the previous users of Lipitor who have developed diabetes as a result of using the drug should inquire to see if they are eligible to make a claim in court and receive a settlement for their medical costs and loss of income.
In some cases, punitive damages may be awarded. Pfizer, the giant pharmaceutical corporation that produces Lipitor has profited well over $100 billion on this sometimes harmful drug.
While the drug is effective at managing high cholesterol levels, it puts some consumers in more danger, health-wise, as it can cause type II diabetes or other serious side effects.
Pursuant to the several filed lawsuits in the U.S alone, the affected women do not understand why the giant pharmaceutical company failed to warn them of the impending danger of taking Lipitor regularly.
A course of just three months is enough to cause the development of type II diabetes in a Lipitor patient. Despite the risks, Pfizer has continued to make billions off the sales of Lipitor each year.
A Short History of the Lipitor Scandal
Lipitor is a trade name or brand used by Pfizer; the generic name of the drug is atorvastatin. Since its production and FDA approval in 1996, the drug has been routinely recommended for persons with high cholesterol.
As years went by the drug became a sensation especially to the American community as cholesterol is an endemic situation due to the type of foods easily available.
Doctors recommended the drug in hospitals and they too were convinced by this wonder drug since it offered amazing results.
The recommendation was justified as the high success rates reported by the users of Lipitor in managing cholesterol was phenomenal except for one serious flaw: the drug can cause serious side effects.
The diabetes rumors were confirmed when a JAMA publication, respectable in scientific and medical circles, reported that post-menopausal women were at a higher risk of developing type II diabetes if they were on a prolonged use of statin drugs such as Lipitor.
Statins are a class of drugs used to manage cholesterol.
Soon after this publication, the USA FDA ordered that the drug warning on the label be improved to include this information so that consumers could be warned adequately. Sixteen years after the release of this drug on the market, the warning came too late for many.
The Lipitor Lawsuits: The Foundation for Future Lipitor Settlements
The Lipitor lawsuits followed shortly after it was proven beyond doubt that Lipitor caused the development of type II diabetes in women who have been on the drug for some time.
The evidence points to negligence by the pharmaceutical corporation since it failed to adequately warn potential users of the drug’s ability to cause type II diabetes in individuals who were otherwise not at risk for contracting the disease.
Lipitor has since caused many users to have to cope with diabetes and high medical expenses.
Having this thought in mind, Lipitor lawsuits became inevitable as people struggled with decreased quality of life in the face of developing type II diabetes.
A Lipitor Settlement is Imminent
Since the drug Lipitor was widely used, the number of plaintiffs who have filed for compensation continues to increase significantly as settlement draws near. The pharmaceutical giant will most likely want to settle rather than let courts award lump sums to affected parties.
Since evidence continues to reveal that Pfizer failed to warn users of the side effects of the Lipitor drug, they are liable for the compensation of any affected person. Evidence that points to users’ lifespan being reduced by five to ten years cannot be ignored in court. Such evidence will speed up a Lipitor settlement.
Lawsuits are detrimental to the business of corporations such as Pfizer, and in order to survive the outcry they will be forced to settle these cases.
Recent Events Confirm a Soon-to-be Lipitor Settlement
Recently in February of 2014, the cases against Pfizer were consolidated and centralized before Judge Richard M. Gergel, as part of a multidistrict litigation. This was done in the Court of South Carolina District.
Every individual case remains just that, a case on its own- not a combined case. This is not a class action lawsuit. If a Lipitor settlement offer is made, the plaintiff has the option of accepting or rejecting it.
Still, if no Lipitor settlement is made, the attorney has to prove that the diabetes was indeed caused by Lipitor. So a good attorney is still a critical requirement to any person who wants compensation in the ongoing Lipitor Settlement Lawsuit.
Negotiations that are done to determine the extent of the drug injury are usually based on the assumption of what a court would likely award that plaintiff. The economic impact on the user and degree of drug injury are also factors taken into consideration when determining the dollar amount of a settlement. Find out if you qualify for a claim today by filling out our online form.
Our evaluation is free and it can be done online or over the phone. We will not charge you for our service unless a settlement is awarded. Our legal services are fair; we are invested in the rights of our clients.
The evaluation process for a Lipitor settlement is free of charge. If you have been affected by this dangerous drug, now is the right time to inquire about your eligibility for a Lipitor settlement.
Choose the Right Representation
Now it is up to you to act. Choose your Lipitor Settlement lawyer or attorney with care as they will either make or break your case. A good attorney will get you a maximum Lipitor settlement while inexperienced representation in court may ensure that you don’t get the compensation you deserve.
Remember that it is up to your attorney to convince the court that you should be compensated highly given the degree of effect the drug has left on you and your family.
Do not take this lightly. Choose qualified Lipitor settlement attorneys and you will ensure a fair compensation plan. Consumer Claim Center of America is a patient advocacy service with experience in processing claims, and we work with the best attorneys in the field.
Fill out the online form on the top right of this page, or call the number below to start your claims process today.
After all, you may have to deal with type II diabetes for the rest of your life. You need to plan your finances accordingly and since Lipitor did this to you, and the responsible corporation should be held liable for any costs arising from this condition.
Lipitor Increases Risk of Diabetes
Lipitor, by Pfizer Pharmaceuticals, is used to treat high cholesterol levels. It works by blocking a certain enzyme (HMG CoA) in the liver, stopping the production of LDL-cholesterol, or “bad” cholesterol.
Lipitor is part of a class of drugs known as statins, which are quite effective in lowering cholesterol levels, but are also known to significantly increase the risk of developing type II diabetes for post-menopausal women.
There are many complications associated with diabetes including heart attacks, stroke, liver damage, kidney failure and more. Diabetes can lead to decreased quality of life, costly medical bills, loss of wages and even death.
In 2012 the U.S. Food and Drug Administration mandated that Pfizer warn patients and healthcare providers about the increased risk of developing type II diabetes.
Many consider this precaution too little and too late, as Lipitor had already been on the market for 16 years.
Because Pfizer failed to inform the public about the dangers of this drug, several lawsuits have been filed against Pfizer’s Lipitor with success.
The Science is in: Lipitor is Dangerous
Well established scientific institutions have found that Lipitor significantly increases the risk of developing type II diabetes.
For example, Yunsheng Ma, MD, PhD, MPH, of the University of Massachusetts Medical School found that Lipitor increased the risk of diabetes by nearly 50% in post-menopausal women.
Over the past decade, supporting evidence has flooded medical journals such as the Lancet, Circulation, the American College of Cardiology, and more showing that Lipitor and other statins significantly increase the risk of developing type II diabetes in post-menpausal women, women who were otherwise at low risk for contracting the disease.
Although the numbers vary slightly from study to study, the bottom line is clear: Lipitor significantly increases the risk of diabetes, a serious and long-term medical condition.
The Case Against Lipitor
Pfizer did not make the increased risk of diabetes known publicly, and consequentially many Lipitor consumers have suffered severe adverse health effects.
If Pfizer had properly informed healthcare providers and patients about the risks associated with their drug, many would have opted a less risky form of treatment. Instead, patients were not given the information they needed to make informed decisions regarding their own healthcare.
When a pharmaceutical company chooses to put its interests first, before the health of consumers, the consequences can be devastating to individuals and their families.
If you feel that you may be eligible for compensation, contact us today. Consumer Claim Center of America is is a patient advocacy service. We will help you determine if you are entitled to a claim, assist throughout the claims process, and connect you with the right attorney.
We are representing women with a body mass index (BMI) of 32 and below, as these women are not typically at high risk for developing type II diabetes. BMI is a measurement that uses a person’s height and weight to determine if they are under weight, of a healthy weight, or overweight.
Contact us today at 1-800-499-6652 or fill out our online form. Please leave a name and contact number and expect a call within 24 hours.